Amit Hazan
Stock Analyst at Goldman Sachs
(2.09)
# 2,965
Out of 5,146 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $59.25 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $8.75 | -71.43% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $0.89 | +2,038.68% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $16.16 | -50.50% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $70.29 | -10.37% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $180.96 | +50.31% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $18.60 | -8.60% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $3.37 | +12,808.01% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $27.84 | +58.05% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $83.40 | -12.47% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $20.73 | +155.67% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $22.32 | +155.38% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $14.04 | -32.34% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $114.76 | -9.38% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $19.66 | +205.19% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $96.65 | +18.99% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $384.03 | -60.94% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $73.48 | -37.40% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $506.17 | -52.26% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $99.85 | +77.27% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $245.17 | -40.04% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.60 | +549.89% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $59.25
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $8.75
Upside: -71.43%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $0.89
Upside: +2,038.68%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $16.16
Upside: -50.50%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $70.29
Upside: -10.37%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $180.96
Upside: +50.31%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $18.60
Upside: -8.60%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $3.37
Upside: +12,808.01%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $27.84
Upside: +58.05%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $83.40
Upside: -12.47%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $20.73
Upside: +155.67%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $22.32
Upside: +155.38%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $14.04
Upside: -32.34%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $114.76
Upside: -9.38%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $19.66
Upside: +205.19%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $96.65
Upside: +18.99%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $384.03
Upside: -60.94%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $73.48
Upside: -37.40%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $506.17
Upside: -52.26%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $99.85
Upside: +77.27%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $245.17
Upside: -40.04%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.60
Upside: +549.89%